Immunovaccine Inc.

Ordinary Shares International Reporting
OTCQX International OTCQX Advisor: Dorsey & Whitney LLP
Verified Company Profile 10/10/2016
Contact Info
  • 1344 Summer Street
  • Suite 412
  • Halifax, NS B3h 0A8
  • Canada

Business Description

Financial Reporting/Disclosure
Reporting Status International Reporting: Toronto Stock Exchange
Audited Financials Audited
Latest Report Jun 30, 2016 Quarterly Report
Fiscal Year End 12/31
OTC Marketplace OTCQX International
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o Mar 31, 2015
Incorporated In: Nova Scotia, Canada
Year of Inc. 2007
Employees 25 a/o Sep 30, 2016
Company Officers/Contacts
Fred Ors CEO
Kimberly Stephens CFO, Corporate Secretary
Brittany Davison Director, Fin.
Company Directors
Andrew Sheldon Chairman
Wade Dawe
Wayne Pisano
Albert Scardino
Alfred Smithers
Shermaine Tilley
Company Notes
  • Formerly=Immuno Vaccine Inc. until 4-2015
Service Providers
OTCQX Advisor
Dorsey & Whitney LLP
1400 Wewatta Street
Suite 400
Denver, CO, 80202

Accounting/Auditing Firm
PricewaterhouseCoopers LLP
1601 Lower Water Street
Suite 400
Halifax, NS, B3J 3P6

Legal Counsel
McCarthy Tetrault LLP
700-1150 de Claire Fontaine
Quebec City, QC, G1R 5G4

Investor Relations Firm
Not Available
IMMVF Security Details
Share Structure
Market Value1 $57,812,076 a/o Oct 24, 2016
Authorized Shares Unlimited a/o Mar 30, 2016
Outstanding Shares 106,861,508 a/o Sep 30, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 77,241,381 a/o Sep 30, 2016
Par Value No Par Value
Shareholders of Record Not Available
Non US Stock Exchange Listing
IMV - Toronto Stock Exchange - Qualified
Short Selling Data
Short Interest 645,528 (66.73%)
Sep 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security